HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With Tucatinib
A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.
Source: onclive.com
Her2 Targeted News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Her2 Targeted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Her2 Targeted Today - Breaking & Trending Today
Landscape of HER2+ Metastatic Breast Cancer: Patient Overview
Expert oncologist Kevin Kalinsky, MD, MS, reviews a patient case of HER2+ metastatic breast cancer and highlights key findings in this disease setting.
Source: onclive.com
MyJournals.org - Science - 'IJMS, Vol. 24, Pages 6228: HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction' (International Journal of Molecular Sciences)
MyJournals.org - Science - 'IJMS, Vol. 24, Pages 6228: HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction' (International Journal of Molecular Sciences)
Source: myjournals.org